Cybin Inc. (NEO:CYBN)
Canada
· Delayed Price · Currency is CAD 13.00
-0.20 (-1.52%)
Feb 21, 2025, 3:57 PM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
271.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 864.00K | - | - |
| Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| dentalcorp Holdings | 1.51B |
| WELL Health Technologies | 957.69M |
| Curaleaf Holdings | 1.83B |
| Sienna Senior Living | 867.55M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |
Cybin News
- 12 days ago - Cybin reports Q3 results - Seeking Alpha
- 12 days ago - Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 4 weeks ago - Cybin: Paradigm Changing Ambitions - Seeking Alpha
- 5 weeks ago - Cybin enters partnership agreement to conduct phase 3 trial for depression candidate - Seeking Alpha
- 5 weeks ago - Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 5 weeks ago - Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 - Business Wire
- 6 weeks ago - Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
- 6 weeks ago - Cybin files $650M mixed securities shelf - Seeking Alpha